Right now, approximately 20 billion red blood cells are busy traveling through your blood vessels. They are delivering oxygen ...

News 8 is once again honoring Black history by looking at health care and the racial disparities many report facing.

The oral small molecules could induce fetal hemoglobin expression. Other companies have hit on the idea of treating sickle cell by inhibiting BACH1. Mitobridge, which Astellas acquired for $225 ...

“It may indicate an underlying health issue such as low hemoglobin or anemia as it is medically called. One of the reasons of anemia can be Sickle Cell Anemia (SCA)—a genetic blood disorder ...

BEAM-101 demonstrated robust and durable increases in fetal hemoglobin and reductions in sickle hemoglobin, showcasing its potential effectiveness in treating sickle cell disease. The safety ...

Currently in preclinical development, IMMvention’s orally dosed BACH1 inhibitors have the potential to increase fetal hemoglobin ... address unmet needs in sickle cell disease and beyond ...

(HealthDay News) — Adults with sickle cell anemia (SCA) and healthy controls with greater economic deprivation have older brain age, according to a study published online Jan. 17 in JAMA Network Open.

Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.